Annual CFF
$8.98 M
+$5.19 M+137.16%
01 December 2023
Summary:
Opus Genetics annual cash flow from financing activities is currently $8.98 million, with the most recent change of +$5.19 million (+137.16%) on 01 December 2023. During the last 3 years, it has fallen by -$12.14 million (-57.49%).IRD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$353.00 K
-$1.19 M-77.08%
01 September 2024
Summary:
Opus Genetics quarterly cash flow from financing activities is currently $353.00 thousand, with the most recent change of -$1.19 million (-77.08%) on 01 September 2024. Over the past year, it has dropped by -$5.02 million (-93.43%).IRD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$7.87 M
-$5.02 M-38.95%
01 September 2024
Summary:
Opus Genetics TTM cash flow from financing activities is currently $7.87 million, with the most recent change of -$5.02 million (-38.95%) on 01 September 2024. Over the past year, it has increased by +$2.51 million (+46.76%).IRD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IRD Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +137.2% | -93.4% | +46.8% |
| 3 y3 years | -57.5% | -77.9% | -79.8% |
| 5 y5 years | - | - | - |
IRD Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -67.5% | -98.2% | -79.9% |
Opus Genetics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $353.00 K(-77.1%) | $7.87 M(-39.0%) |
| June 2024 | - | $1.54 M(-35.2%) | $12.89 M(+13.6%) |
| Mar 2024 | - | $2.38 M(-34.1%) | $11.36 M(+26.5%) |
| Dec 2023 | $8.98 M(+137.2%) | $3.60 M(-33.0%) | $8.98 M(+67.4%) |
| Sept 2023 | - | $5.38 M(>+9900.0%) | $5.36 M(+307.6%) |
| June 2023 | - | $0.00(0.0%) | $1.32 M(-54.7%) |
| Mar 2023 | - | $0.00(-100.0%) | $2.90 M(-23.3%) |
| Dec 2022 | $3.79 M | -$12.00 K(-100.9%) | $3.79 M(-68.0%) |
| Sept 2022 | - | $1.33 M(-16.4%) | $11.83 M(-2.2%) |
| June 2022 | - | $1.59 M(+80.0%) | $12.10 M(-57.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $882.00 K(-89.0%) | $28.48 M(+3.2%) |
| Dec 2021 | $27.61 M(+30.7%) | $8.03 M(+401.9%) | $27.61 M(-29.3%) |
| Sept 2021 | - | $1.60 M(-91.1%) | $39.07 M(+1.8%) |
| June 2021 | - | $17.96 M(>+9900.0%) | $38.40 M(+85.6%) |
| Mar 2021 | - | $10.00 K(-99.9%) | $20.68 M(-2.1%) |
| Dec 2020 | $21.12 M(+349.0%) | $19.50 M(+2010.0%) | $21.12 M(+1200.5%) |
| Sept 2020 | - | $924.00 K(+266.7%) | $1.62 M(+132.0%) |
| June 2020 | - | $252.00 K(-43.8%) | $700.00 K(+56.3%) |
| Mar 2020 | - | $448.00 K | $448.00 K |
| Dec 2019 | $4.70 M | - | - |
FAQ
- What is Opus Genetics annual cash flow from financing activities?
- What is the all time high annual CFF for Opus Genetics?
- What is Opus Genetics annual CFF year-on-year change?
- What is Opus Genetics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Opus Genetics?
- What is Opus Genetics quarterly CFF year-on-year change?
- What is Opus Genetics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Opus Genetics?
- What is Opus Genetics TTM CFF year-on-year change?
What is Opus Genetics annual cash flow from financing activities?
The current annual CFF of IRD is $8.98 M
What is the all time high annual CFF for Opus Genetics?
Opus Genetics all-time high annual cash flow from financing activities is $27.61 M
What is Opus Genetics annual CFF year-on-year change?
Over the past year, IRD annual cash flow from financing activities has changed by +$5.19 M (+137.16%)
What is Opus Genetics quarterly cash flow from financing activities?
The current quarterly CFF of IRD is $353.00 K
What is the all time high quarterly CFF for Opus Genetics?
Opus Genetics all-time high quarterly cash flow from financing activities is $19.50 M
What is Opus Genetics quarterly CFF year-on-year change?
Over the past year, IRD quarterly cash flow from financing activities has changed by -$5.02 M (-93.43%)
What is Opus Genetics TTM cash flow from financing activities?
The current TTM CFF of IRD is $7.87 M
What is the all time high TTM CFF for Opus Genetics?
Opus Genetics all-time high TTM cash flow from financing activities is $39.07 M
What is Opus Genetics TTM CFF year-on-year change?
Over the past year, IRD TTM cash flow from financing activities has changed by +$2.51 M (+46.76%)